Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07056036 · ClinicalTrials.gov registry record · NA
EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings
A NA study of Self-Control and Food Cravings, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 4
- Study locations
NCT07056036 is a NA study of Self-Control and Food Cravings that has completed, run by BTL Industries. The registered enrollment target is 51 participants, below the 555-participant average among 3 other Self-Control trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT07056036, a NA study of Self-Control and Food Cravings, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this clinical trial is to evaluate if the treatment with ExoMIND (BTL-699-2) device is able to improve willpower, self-control and food cravings in adults above the age of 22 years. The main question it aims to answer is: Does the treatment with EXOMIND (BTL-699-2) device improve willpower, self-control and food cravings? Participants will be asked to: * Undergo six treatments * Complete the Brief Self-control Scale * Complete the Food Cravings Questionnaire - Trait * Complete the Therapy Comfort Questionnaire * Complete the Subject Satisfaction Questionnaire
Conditions Studied
Interventions
- DEVICE ActiveTreatment with BTL-699-2
- DEVICE Sham Treatment with BTL-699-2
Study Locations (4)
Colorado
- Aria Integrative Health - Denver
Florida
- A New You Wellness - Miami
Indiana
- Cady Wellness Institute - Newburgh
Ohio
- Jiva Med Spa - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07056036
The ClinicalTrials.gov registry entry for NCT07056036 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 555-participant average among 3 other Self-Control trials with a reported enrollment target (91% lower). The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Self-Control appearing as the primary indexed condition, and to 2 interventions - of which ActiveTreatment with BTL-699-2 is the first listed.
NCT07056036 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Colorado, Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT07056036 about?
NCT07056036 is a clinical study titled "EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings". The goal of this clinical trial is to evaluate if the treatment with ExoMIND (BTL-699-2) device is able to improve willpower, self-control and food cravings in adults above the age of 22 years. The main question it aims to answer is: Does the treatment with EXOMIND (BTL-699-2) device improve willpo...
What is the current status of trial NCT07056036?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2024-11-01. Estimated completion is 2025-10-10.
What conditions does trial NCT07056036 study?
This clinical trial studies the following conditions: Self-Control, Food Cravings.
What interventions are being tested in trial NCT07056036?
The interventions under investigation include: ActiveTreatment with BTL-699-2 (DEVICE), Sham Treatment with BTL-699-2 (DEVICE).
Who is sponsoring clinical trial NCT07056036?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07056036 being conducted?
This trial has 4 study locations across Colorado, Florida, Indiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Self-Control
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.